Regulatory

In a letter to FDA, Jarrow L. Rogovin asks that Daniel Fabricant, PhD, be removed from his post as director of FDA’s Division of Dietary Supplement Programs and for FDA to extend the NDI guidance comment period by a year.

The GRAS acceptance follows on heels of recent FDA acknowledgement of a new dietary ingredient (NDI) notification for Superba krill oil.

Steve Mister, president and CEO of the Council for Responsible Nutrition, praised FDA for the recent warning letter the agency sent Lazy Cakes, the marketer of melatonin-containing brownies.